文献速递青光眼眼底病与葡萄膜炎

OCT检测青光眼进行性黄斑神经节细胞-内丛状层变薄的空间模式

Patterns of Progressive Ganglion Cell-Inner Plexiform Layer Thinning in Glaucoma Detected by OCT.
PubMed 文献 · Ophthalmology · 2018-04-25

这项纵向回顾性观察研究纳入192例原发性开角型青光眼患者的292只眼,平均随访6.0年,用OCT引导进展分析评估黄斑GCIPL进行性变薄的空间特征与模式;24.7%(72/292)出现进行性GCIPL变薄,最常见模式为GCIPL缺损增宽(58.3%),且多数先于或伴随视野进展。

要点

  • 24.7%(72/292只眼)出现进行性GCIPL变薄,最常见于距黄斑中心凹2.08 mm处(25.0%)。
  • 进行性GCIPL变薄最常见模式为缺损增宽(42眼,58.3%),其次为加深(19眼,26.4%)和新发(15眼,20.8%)。
  • 72只眼中41只(56.9%)视野进展伴进行性GCIPL变薄,其中61.0%(25/41)GCIPL变薄先于视野进展。

核心结论

  • OCT GPA图可有效评估青光眼进行性GCIPL变薄的地形模式。
  • 多数青光眼患眼GCIPL变薄进展早于标准自动视野计的明显进展。
  • 理解黄斑损害的具体模式和序列可能为监测青光眼进展提供重要线索。

研究设计与样本

  • 纵向、回顾性、观察性研究,纳入192例原发性开角型青光眼患者的292只眼,平均随访6.0年(范围3.2-8.1年)。
  • 每6个月进行一次黄斑GCIPL成像和视野检查,持续3年以上。
  • 采用Cirrus HD-OCT的GPA设备评估进行性GCIPL变薄,通过GCIPL厚度变化图评估空间特征,比较基线与最终GCIPL厚度偏差图评估模式。
  • 视野进展由早期青光眼试验标准(Early Manifest Glaucoma Trial criteria)和视野指数线性回归判定。

主要发现

  • 72只眼(24.7% [72/292])在GCIPL厚度变化图中显示进行性GCIPL变薄。
  • 进行性GCIPL变薄最常检出(25.0%)于距黄斑中心凹2.08 mm处,并在颞下区域(250°-339°)呈弓形延伸。
  • 与基线GCIPL缺损相比,进行性GCIPL变薄向黄斑中心凹和视盘方向扩展。
  • 进行性GCIPL变薄最常见模式为GCIPL缺损增宽(42眼 [58.3%]),其次为GCIPL缺损加深(19眼 [26.4%])和新发GCIPL缺损(15眼 [20.8%])。
  • 72只眼中41只(56.9%)视野进展伴随进行性GCIPL变薄;其中61.0%(25/41)GCIPL变薄先于视野进展,21.9%(9/41)与视野进展同时发生。

关键数值与推荐

  • 进行性GCIPL变薄检出率24.7%(72/292只眼)。
  • 进行性GCIPL变薄最常检出位置为距黄斑中心凹2.08 mm处(25.0%),颞下区域250°-339°呈弓形延伸。
  • 模式分布:增宽42眼(58.3%)、加深19眼(26.4%)、新发15眼(20.8%)。
  • 视野进展伴GCIPL变薄41/72眼(56.9%),其中先于视野进展61.0%(25/41)、同时发生21.9%(9/41)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the spatial characteristics and patterns of progressive macular ganglion cell-inner plexiform layer (GCIPL) thinning in glaucomatous eyes assessed by OCT Guided Progression Analysis (GPA). DESIGN: Longitudinal, retrospective, observational study. PARTICIPANTS: Two hundred ninety-two eyes of 192 patients with primary open-angle glaucoma with a mean follow-up of 6.0 years (range, 3.2-8.1 years) were included. METHODS: Macular GCIPL imaging and visual field (VF) examination were performed at 6-month intervals for 3 years or more. Progressive GCIPL thinning was evaluated by a Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, CA) GPA device. Spatial characteristics of progressive GCIPL thinning were assessed by the GCIPL thickness change map. The pattern of progressive GCIPL thinning was evaluated by comparing the baseline GCIPL thickness deviation map and the final GCIPL thickness change map. Visual field progression was determined by Early Manifest Glaucoma Trial criteria and linear regression of the VF index. MAIN OUTCOME MEASURES: Spatial characteristics and patterns of progressive GCIPL thinning. RESULTS: Seventy-two eyes of 62 participants (24.7% [72/292]) showed progressive GCIPL thinning in the GCIPL thickness change map. Progressive GCIPL thinning was detected most frequently (25.0%) at 2.08 mm from the fovea, and it extended in an arcuate shape in the inferotemporal region (250°-339°). Compared with the baseline GCIPL defects, the progressive GCIPL thinning extended toward the fovea and optic disc. The most common pattern of progressive GCIPL thinning was widening of GCIPL defects (42 eyes [58.3%]), followed by deepening of GCIPL defects (19 eyes [26.4%]) and newly developed GCIPL defects (15 eyes [20.8%]). Visual field progression was accompanied by progressive GCIPL thinning in 41 of 72 eyes (56.9%). Progressive GCIPL thinning preceded (61.0% [25/41]) or occurred concomitantly with (21.9% [9/41]) VF progression. CONCLUSIONS: The use of OCT GPA maps offers an effective approach to evaluate the topographic patterns of progressive GCIPL thinning in glaucomatous eyes. Progression of GCIPL thinning occurred before apparent progression on standard automated perimetry in most glaucomatous eyes. Understanding specific patterns and sequences of macular damage may provide important insights in the monitoring of glaucomatous progression.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Shin JW, Sung KR, Park SW, et al. Patterns of Progressive Ganglion Cell-Inner Plexiform Layer Thinning in Glaucoma Detected by OCT. Ophthalmology. 2018. PMID: 29705057. doi:10.1016/j.ophtha.2018.03.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。